PTC Therapeutics to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) announced that its executives will present at three upcoming healthcare investor conferences: the Wells Fargo 21st Annual Healthcare Conference on Thursday, Sept. 10 at 9:30 a.m. ET, the 2026 Cantor Global Healthcare Conference on Friday, Sept. 11 at 8:35 a.m. ET, and the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 15 at 9:15 a.m. ET. The presentations will be webcast live and available for 30 days on the Events and Presentations page in the Investor section of the PTC Therapeutics website.
Details
News Market Reaction – PTCT
On Aug 27, the day this news came out, PTCT closed 1.26% below the previous close.
Data tracked by StockTitan Argus for the Aug 27 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wells Fargo 21st Annual Healthcare Conference
Thursday, Sept. 10 at 9:30 a.m. ET
2026 Cantor Global Healthcare Conference
Friday, Sept. 11 at 8:35 a.m. ET
Morgan Stanley 24th Annual Global Healthcare Conference
Tuesday, Sept. 15 at 9:15 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302861390.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.